Indian Journal of Sleep Medicine

Register      Login

VOLUME 1 , ISSUE 1 ( January-March, 2006 ) > List of Articles


Fexofenadine: Assessment of sleepiness potential using objective criteria

J. C. Suri, Pinak Shrikhande, M.K. Sen

Keywords : fexofenadine, sleepiness scale, multiple sleep latency test

Citation Information : Suri JC, Shrikhande P, Sen M. Fexofenadine: Assessment of sleepiness potential using objective criteria. Indian Sleep Med 2006; 1 (1):32-36.

DOI: 10.5005/ijsm-1-1-32

License: NA

Published Online: 01-04-2011

Copyright Statement:  NA


Abstract : To evaluate the sedating effect of fexofenadine by subjective and objective assessment, 28 healthy male subjects were randomized to receive either placebo or fexofenadine 120 mg orally on day 1 or 2. Subjects were subjectively assessed for drowsiness on the basis of Stanford sleepiness scale (SSS) and visual analog scale (VAS). On day 2, multiple sleep latency tests were done at 0930, 1030, 1130, 1230, 1330, 1430, 1530 and 1700 hours. The procedure was repeated on day 3 and 4. Multiple sleep latency test (MSLT) (range) seen with placebo and fexofenadine is 14.36(± 2.83) and 13.5(± 3.66) minutes respectively. There was also no significant difference after fexofenadine and placebo between subjective sleepiness assessed by (VAS) (p=0.05) and (SSS) (p=0.412) respectively.

PDF Share
  1. Nicholson AN, Turner C. Central effects of the H1 – antihistamine, Cetrizine. Aviat Space and Environ Med 1998; 69 (2): 166-70.
  2. Laak AM, Tsai RS, Donne-Op den Kelder, et al. Lipophilicity and hydrogen-bonding capacity of H1 – antihistaminic agents in relation to their central sedative side effects, Eur J Clin Pharmacol 1994; 2(5-6): 373-84.
  3. Meador KJ, Loring DW, Thompson EE, Thompson WO. Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989; 84: 322- 325.
  4. Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side effects. Clin and Experim Allergy 1999; 29 Suppl 3: 133-42.
  5. Nicholson AN, Stone BM. Performance studies with the H1- histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmac 1982; 13: 199-202.
  6. Nicholson AN, Stone BM, Turner C, Mills SL. Antihistamines and aircrew: Usefulness of fexofenadine. Aviat Space and Environ Med 2000; 71: 1-5.
  7. Nicholson AN. Antihistamines. In: Aronson JK ed. Side effects of drugs. Annual 22 Amsterdam: Elsevier, 1999.
  8. Markham A, Wagstaff AJ. Fexofenadine. Drugs 1998; 55(2): 269-74.
  9. Pratt C, Mason J, Russell T et al. Effect of Fexofenadine on corrected QT interval (QTc). Hoechst Marrion Roussel 1997. (data on file).
  10. Vermeeren A, O'Hanion JF. Fexofendine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 1998; 101 (3): 306- 311.
  11. Moser L, Huther KJ, Koch-Weser J, Lundt PV. Effects of terfenadine, diphenhydramine alone and in combination with diazepam or alcohol on psychomotor performance and subjective feelings. Eur J Clin Pharmacol 1978; 14: 417- 23.
  12. Kulshrestha VK, Gupta PP, Turner P, Wadsworth J. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmac 1978; 6: 25-29.
  13. Hoddes E, Zarcone V, Smythe H et al. Quantification of sleepiness: a new approach. Psychophysilogy 1973; 10: 431-436.
  14. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington DC: U.S. Department of Health, Education and Welfare, Public Health Service, 1968.
  15. Association of Sleep Disorders Center's Task Force on daytime sleepiness, Carskadon MA, Chairman. Guidelines for multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9: 519-24.
  16. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, Dement WC, Mitler MM. Excessive daytime sleepiness in man: multiple sleep latency measurements in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978; 45: 621-7.
  17. Dement WC, Carskadon MA, Richardson GS. Excessive daytime sleepiness in sleep apnea syndrome. In: Guilleminault C, Dement WC, eds. Sleep apnea syndromes. New York: Alan R. Liss, Inc., 1978: 23-46.
  18. Carskadon MA, Dement WC. Effects of total sleep loss on sleep tendency. Percept Mot Skills 1978; 48: 495-506.
  19. Carskadon MA, Harvey K, Dement WC. Sleep loss in young adolescents. Sleep 1981; 4: 299-312.
  20. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology 1981; 18: 107-13.
  21. Carskadon MA, Littell WP, Dement WC. Constant routine: alertness, oral body temperature, and performance. Sleep Res 1985; 14: 293.
  22. Mitler MM, van den Hoed J, Carskadon MA, et al. REM sleep episodes during multiple sleep test in narcoleptic patients. Electroencephalogr Clin Neurophysiol 1979; 46: 479-81.
  23. Richardson GS, Carskadon MA, Orav EJ, Dement WC. Circadian variation of sleep tendency in elderly and young adult subjects. Sleep 1982; 5: S82-94.
  24. Carskadon MA, Dement WC. Nocturnal determinants of daytime sleepiness. Sleep 1982: S73-81.
  25. Mitler M. The multiple sleep latency tests an evaluation for excessive somnolence. In: Guilleminault C, ed. Disorders of sleeping and waking: indications and techniques. Menlo Park, California: Addison- Wesley, 1982: 145-153.
  26. Van den Hoed J, Kraemer H, Guilleminault C, et al. Disorders of excessive daytime somnolence: polysomnographic and clinical data for 100 patients. Sleep 1981; 4: 23-27.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.